TREZONOM
LIVE

Serial Number

79228433

Owner

NOVARTIS AG

Filing Date

Jan 18, 2018

Add to watchlist:

No watchlists yet
View on USPTO

TREZONOM Trademark

Serial Number: 79228433 • Registration: 5548037

TREZONOM is a trademark filed by NOVARTIS AG on January 18, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

January 18, 2018

Registration Date

August 28, 2018

Published for Opposition

June 12, 2018

Cancellation Date

September 21, 2022

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Apr 17, 2023 DENC
DEATH OF INTERNATIONAL REGISTRATION
Apr 17, 2023 DETH
NOTIFICATION PROCESSED BY IB
Oct 19, 2018 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Sep 29, 2018 FICS
FINAL DISPOSITION PROCESSED
Sep 29, 2018 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Sep 27, 2018 GPAR
REGISTERED-PRINCIPAL REGISTER
Aug 28, 2018 R.PR
PUBLISHED FOR OPPOSITION
Jun 12, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Jun 8, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 23, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 23, 2018 OP2R
NOTICE OF PUBLICATION
May 23, 2018 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
May 10, 2018 CNSA
ASSIGNED TO EXAMINER
Apr 27, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 16, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 12, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 9, 2018 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Mar 8, 2018 SDRC